Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Callegari is an Italian private medical device and diagnostics company founded in 1930 and headquartered in Parma, Italy. The company designs, manufactures, and markets professional instruments for the medical, pharmaceutical, beauty, and wellness sectors, with a particular emphasis on point-of-care diagnostics and assessment devices. Its product portfolio includes in vitro diagnostic systems such as the CLINI5 line and CliniCrea, as well as skin, vein, and general wellness assessment instruments used by pharmacies, healthcare professionals, and aesthetic operators. Callegari operates commercially through its Italian base and international presence including the United States and Benelux. Historically a pharmaceutical distributor, the business was transformed after acquisition by Catellani Group into a diagnostics and professional device manufacturer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Callegari.